1. Bihan DL, Turner R. Stark DD, Bradley WG, editors. Diffusion and perfusion. Magnetic resonance imaging. 1999. 2nd ed. St. Louis, Mo: Mosby;335–371.
2. Hagen T, Bartylla K, Piepgras U. Correlation of cerebral blood flow measured by stable xenon CT and perfusion MRI. J Comput Assist Tomogr. 1999. 23:257–264.
3. Lythgoe DJ, Ostergaard L, William SC, et al. Quantitative perfusion imaging in carotid artery stenosis using dynamic susceptibility contrast-enhanced magnetic resonance imaging. Magn Reson Imaging. 2000. 18:1–11.
4. Barbier EL, Lamalle L, Decorps M. Methodology of brain perfusion imaging. J Magn Reson Imaging. 2001. 13:496–520.
5. Gibby WA. Zimmerman RA, Gibby WA, Carmody RF, editors. Magnetic resonance angiography and flow imaging. Neuroimaging, clinical and physical principles. 2000. New York: Springer-Verlag;212–219.
6. Cha S, Knopp EA, Johnson G, Wetzel SG, Litt AW, Zagzag D. Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology. 2002. 223:11–29.
7. Forman SD, Cohen JD, Fitzgerald M, Eddy WF, Mintun MA, Noll DC. Improved assessment of significant activation in functional magnetic resonance imaging (fMRI): use of a cluster-size threshold. Magn Reson Med. 1995. 33:636–647.
8. Weiger M, Pruessmann KP, Osterbauer R, Bornert P, Boesiger P, Jezzard P. Sensitivity-encoded single-shot spiral imaging for reduced susceptibility artifacts in BOLD fMRI. Magn Reson Med. 2002. 48:860–866.
9. Knopp EA, Cha S, Johnson G, et al. Glial neoplasms: Dynamic contrast-enhanced T2* weighted MR imaging. Radiology. 1999. 211:791–798.
10. Wittsack HJ, Ritzl A, Fink GR, et al. MR imaging in acute stroke: diffusion-weighted and perfusion imaging parameters for predicting infarct size. Radiology. 2002. 222:397–403.
11. Neumann-Haefelin T, Wittsack HJ, Wenserski F, et al. Diffusion- and perfusion-weighted MRI. The DWI/PWI mismatch region in acute stroke. Stroke. 1999. 30:1591–1597.
12. Roberts HC, Roberts TPL, Brasch RC, Dillon WP. Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. AJNR Am J Neuroradiol. 2000. 21:891–899.
13. Provenzale JM, Wang GR, Brenner T, Petrella JR, Sorensen AG. Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging. AJR Am J Roentgenol. 2002. 178:711–716.
14. Cha S, Knopp EA, Johnson G, et al. Dynamic contrast-enhanced T2*-weighted MR imaging of recurrent malignant gliomas treated with thalidomide and carboplatin. AJNR Am J Neuroradiol. 2000. 21:881–890.
15. Sugahara T, Korogi Y, Tomiguchi S, et al. Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. AJNR Am J Neuroradiol. 2000. 21:901–909.
16. Law M, Cha S, Knopp EA, Johnson G, Arnett J, Litt AW. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Radiology. 2002. 222:715–721.
17. Henry RG, Vigneron DB, Fischbein NJ, et al. Comparison of relative cerebral blood volume and proton spectroscopy in patients with treated gliomas. AJNR Am J Neuroradiol. 2000. 21:357–366.
18. Kiselev VG. On the theoretical basis of perfusion measurements by dynamic susceptibility contrast MRI. Magn Reson Med. 2001. 46:1113–1122.
19. Vonken EP, van Osch MJ, Bakker CJ, Viergever MA. Simultaneous quantitative cerebral perfusion and Gd-DTPA extravasation measurement with dual-echo dynamic susceptibility contrast MRI. Magn Reson Med. 2000. 43:820–827.
20. Yamada K, Gonzalez RG, Ostergaard L, et al. Iron-induced susceptibility effect at the globus pallidus causes underestimation of flow and volume on dynamic susceptibility contrast-enhanced MR perfusion images. AJNR Am J Neuroradiol. 2002. 23:1022–1029.
21. Perkio J, Aronen H, Kangasmaki A, et al. Evaluation of four postprocessing methods for determination of cerebral blood volume and mean transit time by dynamic susceptibility contrast imaging. Magn Reson Med. 2002. 47:973–981.
22. Smith AM, Grandin CB, Duprez T, Mataigne F, Cosnard G. Whole brain quantitative CBF, CBV, and MTT measurements using MRI bolus tracking: implementation and application to data acquired from hyperacute stroke patients. J Magn Reson Imaging. 2000. 12:400–410.
23. Simonsen CZ, Rohl L, Vestergaard-Poulsen P, Gyldensted C, Anderson G, Ostergarrd L. Final infarct size after acute stroke: prediction with flow heterogeneity. Radiology. 2002. 225:269–275.
24. Jackson A, Kassner A, Annesley-Williams D, Reid H, Zhu XP, Li KL. Abnormalities in the recirculation phase of contrast agent bolus passage in cerebral gliomas: comparison with relative blood volume and tumor grade. AJNR Am J Neuroradiol. 2002. 23:7–14.